Pfizer Inc.'s next CEO will be its current Chief Operating Officer Albert Bourla, who will take over the top leadership spot at the big pharma Jan. 1, 2019, succeeding CEO Ian Read. The transition should be a smooth one and comes at a relatively steady point for Pfizer, if not necessarily for the drug industry. Read will remain executive chairman of Pfizer's board of directors.
Talk of a CEO succession plan had begun emerging among investors earlier this year, so the change is not a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?